Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy

Nuclear Medicine Communications

Volumn 27, Issue 6, 2006, Pages 495-499

  Raza, Hasan ^a   Khan, Aakif U ^b   Hameed, Abid ^a   Khan, Ayub ^b  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^b University Campus   (Pakistan)

Author keywords

Salivary gland dysfunction; Salivary gland scintigraphy; Thyroid carcinoma

Indexed keywords

DIAGNOSTIC AGENT; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; IODINE 131;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CROSS-SECTIONAL STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; RADIATION EXPOSURE; RADIATION INJURY; SALIVARY GLAND; SALIVARY GLAND DISEASE; SCINTISCANNING; THYROID TUMOR; TREATMENT OUTCOME; ANALYTIC METHOD; COMPARATIVE STUDY; IODINE 131 UPTAKE TEST; PARAMETER; PAROTID GLAND; QUANTITATIVE ANALYSIS; SALIVARY GLAND SCINTISCANNING; SUBMANDIBULAR GLAND; THYROID CARCINOMA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; SALIVARY GLAND DISEASES; SALIVARY GLANDS; SEVERITY OF ILLNESS INDEX; SODIUM PERTECHNETATE TC 99M; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 33746439487     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200606000-00004     Document Type: Article

References (20)

1. Boice JD Jr. Radiation effects in nuclear medicine. In: Harbert JC, Eckelman WC, Neumann RD, editors. Nuclear medicine diagnosis and therapy. New York: Thieme Medical Publishers; 1996, pp. 279-289.
2. Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med 2002; 27:767-771.
3. Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long term side effects of high dose radioiodine therapy for thyroid carcinoma. J Nucl Med 1998; 39:1551-1554.
4. Solans R, Bosch JA, Galofré P, Porta F, Rosello J, Selva-O'Callaghan A, Vilardell M. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 2001; 42:738-743.
5. Adams BK, Al Attia HM, Parkar S. Salivary gland scintigraphy in Sjögren's syndrome: are quantitative indices the answer. Nucl Med Commun 2003; 24:1011-1016.
6. Aung W, Murata Y, Ishida R, Takahashi Y, Okada N, Hitoshi Shibuya H. Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren's syndrome. J Nucl Med 2001; 42:38-43.
7. Harbert JC. Radioiodine therapy of differentiated thyroid carcinoma. In: Harbert JC, Eckelman WC, Neumann RD, editors. Nuclear medicine diagnosis and therapy. New York: Thieme Medical Publishers; 1996, pp. 975-1010.
8. Fox PC. Acquired salivary gland dysfunction. Drugs and radiation. Ann NY Acad Sci 1998; 842:132-137.
9. Myant NB. Iodine metabolism of salivary glands. Ann NY Acad Sci 1960; 85:208-214.
10. Doniach I. Biologic effects of radiation on the thyroid. In: Werner S, editor. The thyroid. New York: Harper & Row; 1978, pp. 274-283.
11. Goolden AWG, Mallard JR, Farran HEA. Radiation sialoadenitis following radioiodine therapy. Br J Radiol 1957; 30:210.
12. DiRusso G, Kern KA. Comparative analysis of complications from I-131 radioablation for well differentiated thyroid cancer. Surgery 1994; 116:1024.
13. Allweiss P, Braunstein GB, Katz A, Waxman A. Sialoadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 1984; 25:755-758.
14. Rodrigues M, Havlik E, Peskar B, Sinzinger H. Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy? Eur J Nucl Med 1998; 25:265-269.
15. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Tonshoff G, Wolf H, et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun 1996; 17:681-686.
16. Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys 1996; 35:535-540.
17. Albrecht HH, Creutzig H. Salivary gland scintigraphy after radioiodine therapy. Functional scintigraphy of the salivary gland after high dose radioiodine therapy. Fortschr Roentgenstr 1976; 125:546-551.
18. Olmos RA, Keus RB, Takes RP, van Tinteren H, Hilgers FJ, Baris G, et al. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands. Cancer 1994; 73:2886-2893.
19. Liem IH, Olmos RA, Balm AJ. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumors. Eur J Nucl Med 1996; 23:1845-1890.
20. Stephens LC, Schulthesis TE, Price RE, Ang KK, Peters LJ. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer 1991; 67:1539.